• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Parylene Coatings for Medical Device Technologies

    The Big Shift: Nearshoring Trends in Medtech Manufacturing

    OEMs Seek Molders Offering Timely Techniques

    Robotic Surgery: Cutting Through to the Latest

    Packaging, Sterilization Considerations Go Part and Parcel with Product Development
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    Endologix's AFX2 Endovascular AAA System Earns EU Nod

    Elizabeth Coleon Joins Withings as Chief Marketing Officer

    U.K. Strengthens Medical Device Regulations

    Fujirebio Acquires ADx NeuroSciences

    IVD Market to Decline Steadily by 2030
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Parylene Coatings for Medical Device Technologies

    The Big Shift: Nearshoring Trends in Medtech Manufacturing

    OEMs Seek Molders Offering Timely Techniques

    Robotic Surgery: Cutting Through to the Latest

    Packaging, Sterilization Considerations Go Part and Parcel with Product Development
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Cooling and Melting the Pain Away

    What Are the Fundamentals of Go-To-Market Strategy in Medical Devices?

    Minding the Gap: How Harmonizing Quality Systems Pays Off

    Building Strong Partnerships Between Medtech and Surgeon-Learning Platforms

    Four Key Considerations for OEMs Transferring a Product Program
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Cirtec Medical

    BMP Medical

    Trademark Plastics Inc.

    Xact Wire EDM Corp.

    Concise Engineering
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    The Importance of Building Successful Supplier Relationships

    The Benefits of Outsourcing Innovation in Medtech Manufacturing

    Patching Healthcare Cybersecurity Risks in the Internet of Medical Things

    Leveraging Open Healthcare Data Standards to Improve Medical Device Manufacturing

    3 Ways Privacy-Enhancing Technology Will Improve Medical Products Innovation
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Cirtec Medical

    BMP Medical

    Trademark Plastics Inc.

    Xact Wire EDM Corp.

    Concise Engineering
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    FDA Designates N8 Medical's CeraShield Endotracheal Tube as a Breakthrough Device

    Device is a specially-modified endotracheal tube coated with a proprietary ceragenin compound formulation.

    Related CONTENT
    • Phillips-Medisize Names New VP
    • Four Takeaways from Recent Regulatory Audit Changes
    • FDA Clears First Whole Slide Imaging System for Digital Pathology
    • Collaborating on Custom Materials Development
    • Extractable/Leachable Chemistry Testing Strategies for Medical Devices
    N8 Medical LLC04.24.17
    The U.S. Food and Drug Administration (FDA) has agreed to designate NA Medical LLC's CeraShield endotracheal tube as a breakthrough device pursuant to the recently enacted 21st Century Cures Act. A breakthrough device is a product that may prevent a life-threatening or irreversibly debilitating disease or condition.  
     
    Each year more than 4 million Americans hospitalized in intensive care units (ICUs) require the use of an endotracheal tube attached to a ventilator to help them breathe. Bacteria and fungi quickly grow on these tubes and may lead to potentially deadly respiratory infections and other severe complications. N8 supported its filing with FDA with recent data from the U.S. Centers for Disease Control and Prevention (CDC) showing that the antimicrobial compound in the CeraShield endotracheal tube can inhibit growth of all 100 strains of candida auris—an emerging highly lethal fungal infection. While Candida auris infections have been found overseas, they have only recently been found in U.S. hospitals with recent outbreaks in Boston, Mass., and New York, N.Y. N8 also supplied the FDA with peer-reviewed published data showing efficacy against multidrug resistant bacterial strains such as colistin resistant pseudomonas and acinetobacter. Colistin is regarded as the antibiotic of last resort.
     
    The 21st Century Cures Act enables companies to use a combination of premarket and postmarket approval studies to meet the requirements for a faster pathway toward approval. This significantly expedites access for U.S. patients and their physicians to innovative medical devices. The statute was enacted in January 2017 for medical devices that demonstrate the potential to address unmet medical needs for life-threatening or irreversibly debilitating diseases or conditions, such as ventilator  associated pneumonia and ventilator associated tracheobronchitis as well as other respiratory infections.
     
    Ceragenins are mimics of molecules found within the human body’s own innate immune system, and were invented by Dr. Paul B. Savage, The Reed Izatt professor of chemistry and biochemistry at Brigham Young University in Provo, Utah. There are more than 40 peer-reviewed journal articles on the ceragenin technology, and the technology is protected by issued patents through 2033. Brigham Young has licensed the ceragenin technology to N8 Medical for certain fields of use, including application to medical devices.
     
    The N8 Medical’s CeraShield Endotracheal Tube is a specially-modified endotracheal tube that has been coated with a proprietary ceragenin compound formulation designed to prevent bacterial and fungal growth on the tube’s surfaces. Patients who require mechanical ventilation in the ICU are intubated with endotracheal tubes to provide oxygen to the patient’s lungs to assist the patients’ breathing. Within hours of intubation, bacteria and fungi may start to grow on the tube and form microbial aggregations known as biofilms. Biofilms consist of millions of bacteria and/or fungi and are almost impossible to eradicate through use of ordinary antibiotics.

    “Among the potential benefits of the technology are that it may reduce mortality, cost of care and improve clinical outcomes for ICU patients requiring mechanical ventilation, as well as slow or prevent the development of new antimicrobial resistant bacterial and fungal strains,” said Carl Genberg, CEO of N8 Medical LLC.  
     
    Once a mature biofilm forms  on an endotracheal tube, fragments may break apart and migrate to the lower respiratory tract causing difficult to treat, potentially lethal respiratory infections. Such infections are called nosocomial or hospital-acquired infections. Nosocomial infections associated with the use of endotracheal tubes are among the most common and most deadly of nosocomial infections. According to the U.S. Department of Health and Human Services (HHS), nosocomial infections claim the lives of nearly 100,000 Americans each year and add billions to the annual healthcare expenditures in the United States and globally.  Approximately 70 percent of such nosocomial infections are believed to be related to the use of indwelling medical devices. Indwelling devices provide a “protected” breeding ground for bacteria and fungi that can lead to these life-threatening infections. Neonates, the elderly and immune compromised patients are at highest risk for such infections.
     
    Particularly concerning is the emergence of multidrug-resistant pathogens, such as colistin-resistant strains of pseudomonas aeruginosa and acinetobacter baumannii, as well as the recently identified highly lethal fungus—candida auris. Candida auris has been the subject of a CDC nationwide alert in June 2016 to healthcare institutions. CDC has recently tested CSA-131, the ceragenin in the CeraShield Endotracheal Tube, against CDC’s collection of 100 clinical isolates of candida auris from around the world and representing four separate genetic clusters. Many of these isolates are highly-resistant to fluconazole, a potent anti-fungal agent, and some are resistant to all commercially available antifungals. The CDC testing found that CSA-131 was active against all 100 strains of candida auris with a maximum minimum inhibitory concentration (MIC) of 1 micrograms/ml for all strains, and some strains with MICs of 0.5 micrograms/ml.
     
    The CeraShield medical device coating technology is applicable to a broad range of medical devices commonly colonized with pathogenic bacteria and fungi, including urology, vascular access, cardiology, orthopedics, and ear vents, as well as other respiratory devices such as tracheostomy tubes as these devices may also be colonized with pathogenic bacteria and fungi.
     
    Ronald Bracken, N8 Medical’s president and chief operating officer, a medical device industry veteran and formerly vice president of research and development for C.R. Bard, added, “As someone who has developed and brought to market antimicrobial medical devices for over 20 years, I believe that the CeraShield technology is unparalleled in its broad spectrum antimicrobial, antifungal and anti-inflammatory activity and I look forward to working with FDA to expedite the approval of this truly breakthrough device.”
     
    “The breakthrough designation is an incredible opportunity to accelerate the path to approval in the United States, and we are honored to have been chosen to be among the small handful of devices that have met the FDA’s requirements for this designation,” said David J. Richards, N8 Medical's board chairman. “We now look forward to working closely with the FDA to try to reduce the time to get devices to the patients that need them, while still maintaining the high standards of safety, efficacy and scientific validity required by the program.”
     
    The modern age of antibiotic therapy began with the discovery and introduction of penicillin. Penicillin in was rightly regarded as a “wonder drug” or “magic bullet” as patients at death’s door in hospitals were cured of their infections and sent home to resume normal lives. However, widespread use of the drug led to the development of new strains of bacteria resistant to penicillin. A modified form of penicillin—methicillin—was thereafter developed, and similarly widespread use of that drug led to methicillin led to highly virulent methicillin-resistant staph aureus (MRSA).  Widespread use of other antibiotics has also led to the emergence of deadly multidrug-resistant strains. The World Health Organization and other health agencies have repeatedly warned that humanity may be entering a “post-antibiotic” age and could be at the end of the modern era of antibiotic therapy due to the lack of development of new effective antibiotics.
     
    Prior to the introduction of modern antibiotics, infections were a leading cause of death in the United States and elsewhere. The lack of antibiotic therapy for newly-emerging antibiotic resistant strains is posing a serious threat to global health. According to a study commissioned by David Cameron, the United Kingdom’s former prime minister, if urgent action is not taken to develop new countermeasures, the annual worldwide death rate may reach 10 million persons per year by 2050, with a loss of global economic production between $100 trillion by 2050. N8 Medical believes that its CeraShield coating technology is poised and ideally-suited to address this major worldwide health concern. 

    “In clinical practice, we regularly observe that despite high levels of antibiotic use, some mechanically ventilated patients in the ICU still go on to develop complications such as ventilator associated pneumonia and ventilator associated tracheobronchitis, which may lead to poor clinical outcomes, including death," said Professor Michael Niederman, chairman of N8 Medical’s Scientific Advisory Board and associate division chief, clinical director of pulmonary and critical care at New York Presbyterian /Weill Cornell Medical Center. "Here is a great need to find new approaches to protect and treat such patients that will reduce the need for systemic antibiotic therapy while improving patient outcomes.”
     
    In the United States, the CeraShield endotracheal tube is limited by law to investigational use only.

    N8 Medical LLC is a privately-held company developing novel solutions for the prevention of hospital-acquired infections from multidrug-resistant pathogens.
    Related Searches
    • utah
    • bacteria
    • coating
    • intubation
    Suggested For You
    Phillips-Medisize Names New VP Phillips-Medisize Names New VP
    Four Takeaways from Recent Regulatory Audit Changes Four Takeaways from Recent Regulatory Audit Changes
    FDA Clears First Whole Slide Imaging System for Digital Pathology FDA Clears First Whole Slide Imaging System for Digital Pathology
    Collaborating on Custom Materials Development Collaborating on Custom Materials Development
    Extractable/Leachable Chemistry Testing Strategies for Medical Devices Extractable/Leachable Chemistry Testing Strategies for Medical Devices
    ASTM Guide Supports Cleaning Protocols for Reusable Medical Devices ASTM Guide Supports Cleaning Protocols for Reusable Medical Devices
    Software’s Coming of Age Software’s Coming of Age
    Four Common Misperceptions of Accelerated FDA Approval Four Common Misperceptions of Accelerated FDA Approval
    Pace of Medtech M&A Activity Not Likely to Abate in 2017 Pace of Medtech M&A Activity Not Likely to Abate in 2017
    FDA Approves Increase in Number of Clinical Sites for E-QURE’s Pivotal Trial of BST Device FDA Approves Increase in Number of Clinical Sites for E-QURE’s Pivotal Trial of BST Device
    Magnetic Latches for Medical Devices Magnetic Latches for Medical Devices
     FlowAid Receives FDA Clearance for the FA100 SCCD FlowAid Receives FDA Clearance for the FA100 SCCD
    Capillus Laser Therapy Caps Receive FDA Clearance for Over-the-Counter Use Capillus Laser Therapy Caps Receive FDA Clearance for Over-the-Counter Use
    FDA Clears Voxello FDA Clears Voxello's Speech Generation Device
    Clariant/SICPA PLASTIWARD Anti-Counterfeiting System Makes U.S. Debut Clariant/SICPA PLASTIWARD Anti-Counterfeiting System Makes U.S. Debut

    Related Breaking News

    • Phillips-Medisize Names New VP

      Phillips-Medisize Names New VP

      Michael Ratigan has been appointed vice president of global sales.
      Phillips-Medisize 05.18.17

    • Four Takeaways from Recent Regulatory Audit Changes

      Four Takeaways from Recent Regulatory Audit Changes

      ...
      Alexa Sussman, Content Marketing Writer, EtQ 05.01.17

    • Diagnostics | Digital Health | Electronics | Software & IT
      FDA Clears First Whole Slide Imaging System for Digital Pathology

      FDA Clears First Whole Slide Imaging System for Digital Pathology

      Philips IntelliSite Pathology Solution cleared for primary diagnostic use.
      U.S. Food and Drug Administration 04.13.17


    • Materials | R&D & Design
      Collaborating on Custom Materials Development

      Collaborating on Custom Materials Development

      OEMs and contractors can engage with materials suppliers for custom formulations and product development.
      Deepak Prakash, Vancive Medical Technologies 04.03.17

    • Testing
      Extractable/Leachable Chemistry Testing Strategies for Medical Devices

      Extractable/Leachable Chemistry Testing Strategies for Medical Devices

      ...
      Matthew R Jorgensen, Ph.D., and Thor Rollins, BS, Nelson Laboratories; Allison Komiyama, Ph.D., RAC, AcKnowledge RS 04.03.17

    Loading, Please Wait..

    Trending
    • U.K. Strengthens Medical Device Regulations
    • Portable, Home-Use Device Quickly Measures Inflammation Levels
    • How Are Hypodermic Needles Made?
    • Microneedle Patch Glucose Monitor Proves Virtually Painless And More Accurate
    • The Future Of Biomedical Engineering Advancements
    Breaking News
    • Medidata Unveils New Tech to Improve Clinical Trial Oversight
    • BD, Direct Relief, NACHC Award $1M Grant for Health Equity
    • Domestic Production Key to India's Medtech Manufacturing Success
    • FDA OKs Bodyport's Cardiac Scale, a Noninvasive Biomarker Platform
    • Stratasys to Buy Covestro's 3D Printing Materials Biz for €43M
    View Breaking News >
    CURRENT ISSUE

    July/August 2022

    • Parylene Coatings for Medical Device Technologies
    • Nearshoring Trends in Medtech Manufacturing
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Flower Pollen Extract Benefits Women’s Urinary Incontinence, Study Finds
    3i Solutions Announces New Leadership Positions
    INS Nutra Opens Gummy Manufacturing Facility
    Coatings World

    Latest Breaking News From Coatings World

    Lanxess' Entire Value Chain to Become Climate-Neutral
    Custom Cars Featuring PPG DELTRON Refinish System Take Awards at Goodguys 24th Summit
    HGTV Home by Sherwin-Williams Announces 2023 Color Collection of the Year
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Endologix's AFX2 Endovascular AAA System Earns EU Nod
    Elizabeth Coleon Joins Withings as Chief Marketing Officer
    U.K. Strengthens Medical Device Regulations
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Pfizer to Acquire Global Blood Therapeutics for $5.4B
    BioIVT Acquires Scottish Drug-metabolizing Enzyme Manufacturer Cypex
    Schott Creates Stand-Alone Company for its Pharma Business
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Cetaphil Announces Clean Formulas & Commits to Sustainability
    Batiste Kicks Off Partnership with Fitness Brand
    The Body Shop Expands Partnership with Uber
    Happi

    Latest Breaking News From Happi

    Hallstar To Purchase Lanxess’ Polymer Additives Production Site in Greensboro, NC
    Uber and The Body Shop Expand On-Demand Delivery Partnership Nationwide
    Australia-Based Teeth Whitening Technology Leader White Glo Enters US Market
    Ink World

    Latest Breaking News From Ink World

    Xerox Board of Directors Names Steven Bandrowczak as CEO
    ALTANA AG to Sell Its Stake in dp polar to 3D Systems
    Weekly Recap: Zeller+Gmelin, Epple Druckfarben Lead This Week’s News Stories
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Eukalin acquires Adhesives Specialists
    EyeC unveils new inspection products
    Errol Moebius named VP of IST America
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Weekly Recap: A New Day for Hygiene, Glatfelter Reports Q2 Results & More
    Dyper Achieves B Corp Certification
    Edgewell’s Sales Grow
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    OSSIO Rolls Out OSSIOfiber Suture Anchors in U.S.
    MicroPort Navibot’s SkyWalker System Cleared by FDA
    NuVasive Inc. Reports Q2 2022 Financial Results
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    CdTe Accelerator Consortium Aims to Reduce Costs, Speed Deployment
    Universal Display Announces Retirement Plans of CFO Sidney D. Rosenblatt
    Fast Company Names Zebra Technologies to 2022 Best Workplaces for Innovators

    Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login